These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 30763621)

  • 41. Regulated cell death in cancer: from pathogenesis to treatment.
    Gong L; Huang D; Shi Y; Liang Z; Bu H
    Chin Med J (Engl); 2023 Mar; 136(6):653-665. PubMed ID: 35950752
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nanomaterial-induced autophagy: a new reversal MDR tool in cancer therapy?
    Panzarini E; Dini L
    Mol Pharm; 2014 Aug; 11(8):2527-38. PubMed ID: 24921216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeting regulated cell death in tumor nanomedicines.
    Zeng Q; Ma X; Song Y; Chen Q; Jiao Q; Zhou L
    Theranostics; 2022; 12(2):817-841. PubMed ID: 34976215
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytotoxicity of a naturally occuring spirostanol saponin, progenin III, towards a broad range of cancer cell lines by induction of apoptosis, autophagy and necroptosis.
    Mbaveng AT; Chi GF; Nguenang GS; Abdelfatah S; Tchangna Sop RV; Ngadjui BT; Kuete V; Efferth T
    Chem Biol Interact; 2020 Aug; 326():109141. PubMed ID: 32454006
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nanomaterial applications in multiple sclerosis inflamed brain.
    Ballerini C; Baldi G; Aldinucci A; Maggi P
    J Neuroimmune Pharmacol; 2015 Mar; 10(1):1-13. PubMed ID: 25616566
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Deoxypodophyllotoxin triggers necroptosis in human non-small cell lung cancer NCI-H460 cells.
    Wu M; Jiang Z; Duan H; Sun L; Zhang S; Chen M; Wang Y; Gao Q; Song Y; Zhu X; Zhang L
    Biomed Pharmacother; 2013 Oct; 67(8):701-6. PubMed ID: 23896261
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.
    Piktel E; Niemirowicz K; Wątek M; Wollny T; Deptuła P; Bucki R
    J Nanobiotechnology; 2016 May; 14(1):39. PubMed ID: 27229857
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics.
    Ahmad IZ; Kuddus M; Tabassum H; Ahmad A; Mabood A
    Curr Drug Metab; 2017; 18(11):983-999. PubMed ID: 28969548
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Targeted nanomedicine in diagnostics and therapy of neurological diseases].
    Bertalan F; László B; Attila V
    Ideggyogy Sz; 2013 May; 66(5-6):155-63. PubMed ID: 23909015
    [TBL] [Abstract][Full Text] [Related]  

  • 50. "Combo" nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy.
    Kemp JA; Shim MS; Heo CY; Kwon YJ
    Adv Drug Deliv Rev; 2016 Mar; 98():3-18. PubMed ID: 26546465
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nanomaterials for theranostics: recent advances and future challenges.
    Lim EK; Kim T; Paik S; Haam S; Huh YM; Lee K
    Chem Rev; 2015 Jan; 115(1):327-94. PubMed ID: 25423180
    [No Abstract]   [Full Text] [Related]  

  • 52. The role of necroptosis in pulmonary diseases.
    Mizumura K; Maruoka S; Gon Y; Choi AM; Hashimoto S
    Respir Investig; 2016 Nov; 54(6):407-412. PubMed ID: 27886851
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metal Oxide Nanomaterials in Nanomedicine: Applications in Photodynamic Therapy and Potential Toxicity.
    He X; Aker WG; Huang MJ; Watts JD; Hwang HM
    Curr Top Med Chem; 2015; 15(18):1887-900. PubMed ID: 25961519
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Application of Metallic Nanomaterials in Nanomedicine.
    Singh MR
    Adv Exp Med Biol; 2018; 1052():83-102. PubMed ID: 29785483
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic targets in the selective killing of cancer cells by nanomaterials.
    Akhtar MJ; Ahamed M; Alhadlaq HA
    Clin Chim Acta; 2017 Jun; 469():53-62. PubMed ID: 28342712
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recent Advances in Managing Atherosclerosis via Nanomedicine.
    Chan CKW; Zhang L; Cheng CK; Yang H; Huang Y; Tian XY; Choi CHJ
    Small; 2018 Jan; 14(4):. PubMed ID: 29239134
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Au-nanomaterials as a superior choice for near-infrared photothermal therapy.
    Jabeen F; Najam-ul-Haq M; Javeed R; Huck CW; Bonn GK
    Molecules; 2014 Dec; 19(12):20580-93. PubMed ID: 25501919
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intracellular and extracellular targets as mechanisms of cancer therapy by nanomaterials in relation to their physicochemical properties.
    Andraos C; Gulumian M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Mar; 13(2):e1680. PubMed ID: 33111484
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Silicon nanomaterials platform for bioimaging, biosensing, and cancer therapy.
    Peng F; Su Y; Zhong Y; Fan C; Lee ST; He Y
    Acc Chem Res; 2014 Feb; 47(2):612-23. PubMed ID: 24397270
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mitigation of Amyloidosis with Nanomaterials.
    Ke PC; Pilkington EH; Sun Y; Javed I; Kakinen A; Peng G; Ding F; Davis TP
    Adv Mater; 2020 May; 32(18):e1901690. PubMed ID: 31183916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.